<?xml version="1.0" encoding="UTF-8"?>
<p>Similarly, a statistically significant reduction (
 <italic>p</italic> â‰¤ 0.0433) in infectious PRVABC59 ZIKV titers as measured by TCID
 <sub>50</sub> quantification was observed in castanospermine-, celgosivir- and DNJ-treated Vero (
 <xref ref-type="fig" rid="F1">Figures 1E</xref>, 
 <xref ref-type="fig" rid="F2">2E</xref>, 
 <xref ref-type="fig" rid="F3">3E</xref>) and CHME3 cells (
 <xref ref-type="fig" rid="F1">Figures 1F</xref>, 
 <xref ref-type="fig" rid="F2">2F</xref>, 
 <xref ref-type="fig" rid="F3">3F</xref>) infected with PRVABC59 ZIKV at both MOI 0.5 and MOI 5, with the exception of a reduction in castanospermine-treated CHME3 cells infected at MOI 0.5 which was not statistically significant.
</p>
